wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38685006-85810D8B-EC38-4456-AFF4-7CF54B0835BB
Q38685006-85810D8B-EC38-4456-AFF4-7CF54B0835BB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38685006-85810D8B-EC38-4456-AFF4-7CF54B0835BB
Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.
P2860
Q38685006-85810D8B-EC38-4456-AFF4-7CF54B0835BB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38685006-85810D8B-EC38-4456-AFF4-7CF54B0835BB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
50ad68f8ea0bee581cc3f0073ef73c0a8c91ef4f
P2860
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies